Drug Shortage Report for POTASSIUM ACETATE INJECTION USP

Last updated on 2017-11-21 History
Report ID 21765
Drug Identification Number 02362597
Brand name POTASSIUM ACETATE INJECTION USP
Common or Proper name Potassium Acetate
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) POTASSIUM ACETATE
Strength(s) 39.2%
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 10 x 50mL vial
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-10-13
Actual start date 2017-10-05
Estimated end date 2017-12-01
Actual end date 2017-11-20
Shortage status Resolved
Updated date 2017-11-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2017-11-21 English Compare
v9 2017-11-20 French Compare
v8 2017-11-20 English Compare
v7 2017-11-13 French Compare
v6 2017-11-13 English Compare
v5 2017-10-14 English Compare
v4 2017-09-18 French Compare
v3 2017-09-18 English Compare
v2 2017-09-08 French Compare
v1 2017-09-08 English Compare

Showing 1 to 10 of 10